The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.

which specializes in AI platforms for antigen discovery, has reported one-year interim data from a Phase II trial (NCT05309421) underway for its peptide-based personalized cancer vaccine candidate ...

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

A breakthrough in preclinical data puts CK Life Sciences at the forefront of next-gen immuno-oncology. Abstract 853: ...

Is it possible—as OpenAI’s Sam Altman has mused—that one day we’ll simply ask ChatGPT to cure cancer ... 200 “AI-first” biotechs, and by January 2024, at least 75 drugs or vaccines ...

The first trial of an AI-powered chatbot designed to inform parents about the HPV vaccine has shown that it increases vaccine uptake and engagement with health professionals. Cervical cancer ...

The targeting of lung cancer is particularly significant ... With some mRNA approaches also using AI to personalise each vaccine to the patient, there are also questions about how to regulate ...

1 This article explores how mRNA vaccine platforms are expanding into new disease areas, from flu to cancer, and what this means for biotech innovation. mRNA vaccines work by using synthetic mRNA ...

Personalised cancer vaccines offer significant potential ... a multidisciplinary approach that brings together experts in vaccines, ATMPs, AI and machine learning, regulatory requirements, and ...

The first trial of an AI (Artificial Intelligence ... has shown that it increases vaccine uptake and engagement with health professionals. Cervical cancer, caused by human papillomavirus (HPV ...